Anthem Biosciences Limited has informed the Exchange about Schedule of meet
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Limited has informed the exchanges about a scheduled earnings conference call to discuss the Q4 and FY2026 audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The call is scheduled for Wednesday, May 20, 2026 at 11:00 AM IST. JM Financial Institutional Securities Limited is organizing the call, with participation from Managing Director and CEO Ajay Bhardwaj and Chief Financial Officer Gawir Baig. The company has provided dial-in numbers for investors to join the call. This disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The scheduled earnings call indicates that Q4 and FY2026 financial results are expected to be released prior to May 20, 2026. Investors can participate to hear management's discussion on the company's financial performance for the quarter and full year ended March 31, 2026.